Commenting on the Company’s performance, Sequoia’s Chairman Michael Carter said, “The Board is very pleased with the Company’s steady progress and the delivery of another strong financial result this quarter. We have a robust business development pipeline in place and a growing number of cross divisional opportunities for our products and services suite. As a result the outlook for growth in the year ahead remains very positive.”
Still looks great value at sub 40c at a minimum.
- Forums
- ASX - By Stock
- Ann: Appendix 4C - Quarterly
SEQ
sequoia financial group ltd
Add to My Watchlist
1.43%
!
35.5¢

Commenting on the Company’s performance, Sequoia’s Chairman...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
35.5¢ |
Change
0.005(1.43%) |
Mkt cap ! $43.87M |
Open | High | Low | Value | Volume |
35.5¢ | 35.5¢ | 35.0¢ | $37.20K | 105.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 56039 | 35.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
35.5¢ | 19052 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 50325 | 0.350 |
1 | 2944 | 0.340 |
1 | 2982 | 0.335 |
1 | 3000 | 0.330 |
2 | 69535 | 0.315 |
Price($) | Vol. | No. |
---|---|---|
0.355 | 19052 | 2 |
0.360 | 134902 | 2 |
0.365 | 72540 | 3 |
0.370 | 33513 | 2 |
0.375 | 89000 | 3 |
Last trade - 15.00pm 27/06/2025 (20 minute delay) ? |
Featured News
SEQ (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online